Susquehanna International Group’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,300
Closed -$23K 14053
2022
Q3
$23K Sell
26,300
-1,100
-4% -$1.33K ﹤0.01% 12560
2022
Q2
$31K Sell
27,400
-9,100
-25% -$7.81K ﹤0.01% 12211
2022
Q1
$51K Sell
36,500
-8,100
-18% -$17.3K ﹤0.01% 12306
2021
Q4
$152K Buy
44,600
+10,100
+29% +$56.9K ﹤0.01% 11780
2021
Q3
$305K Buy
+34,500
New +$454K ﹤0.01% 10573

Other funds holding AFIB

Susquehanna International Group's AFIB Position: Q4 2023 in Review

Susquehanna International Group sold out of Acutus Medical Inc (AFIB) in Q4 2023, closing a stake of 10,753 shares — an estimated $7.49K sold.

Susquehanna International Group first reported a position in AFIB in Q3 2021 and held it in 7 quarters. The position peaked at $781K in Q3 2021. 29 funds tracked by Wall St. Rank hold AFIB as of Q4 2023.

  • Susquehanna International Group reported no remaining Acutus Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 10,753 Acutus Medical Inc shares in Q4 2023, an estimated $7.49K.
  • Susquehanna International Group first reported a position in Acutus Medical Inc in Q3 2021 and held it in 7 quarters.
  • Susquehanna International Group's Acutus Medical Inc position peaked at $781K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.